I agree Ken, the company is just starting a huge upswing and financials are just the beginning.
News will get better and better imo:
3-11-19: Sunnyvale, March 11, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, increases weekly guidance for medical billing associated with its physician-prescribed allergy testing services from $1,000,000 ($1 million) per week as presented in the December 31 2018 CEO Letter to Shareholders, to $2,000,000 ($2 million) per week effective immediately. The 100% weekly guidance increase from $1 million to $2 million per week for fiscal year 2019 (FY2019) is based on medical billing growth during the first quarter of FY2019, the number of new clinics being added to our Patient Data Solutions portal, and the rate of allergy testing services adoption in the marketplace. https://www.marketwatch.com/press-release/arrayit-corporation-increases-weekly-guidance-for-doctor-prescribed-allergy-testing-clinical-services-2019-03-11-61844929?siteid=bigcharts&dist=bigcharts
3-19-19: Arrayit senior management receives senior exchange listing information from up-listing experts http://Uplisting.com headquartered in New York NY USA and facilitating NASDAQ listings by maximizing public company business goals and shareholder value http://www.uplisting.com
Arrayit senior management receives senior exchange listing information from up-listing experts https://t.co/NFJbS1d3eS headquartered in New York NY USA and facilitating NASDAQ listings by maximizing public company business goals and shareholder value https://t.co/C3d6MWsQbTpic.twitter.com/ZmF5BXL7av
3-26-19: Sunnyvale, March 25, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, is working closely with an Apple enterprise healthcare partner to increase revenues and earnings for fiscal year 2019 (FY2019). This new partnership leverages the widely used Apple iPad platform and iPhone operating system (iOS) to streamline key aspects of Arrayit doctor-prescribed allergy testing services including patient scheduling, test kit ordering, electronic retrieval of test results and requests for ancillary treatment options, all in manner this is fully compliant with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Arrayit's convenient finger stick testing services are being increasingly utilized by doctors to detect, manage and treat allergy and asthma, which impact approximately 60 million Americans annually. https://www.marketwatch.com/press-release/arrayit-corporation-appoints-apple-enterprise-healthcare-partner-to-accelerate-fy2019-revenues-and-earnings-growth-2019-03-25-51843036?siteid=bigcharts&dist=bigcharts
3-28-19: 3-28-19: Arrayit clinical sales team reports $2,000,000 clinical testing services sales to leading health benefits payers providing premium government and commercial healthcare coverage to 100 million+ Americans in the massive $3 trillion US healthcare markets http://arrayit.com/Clinical/Allergy_Test/allergy_test.html …
Arrayit clinical sales team reports $2,000,000 clinical testing services sales to leading health benefits payers providing premium government and commercial healthcare coverage to 100 million+ Americans in the massive $3 trillion US healthcare markets https://t.co/To67BQtJJqpic.twitter.com/aXRA91wkrd
this is irresponsible and you should have more respect for yourself and your money. They have no choice the financials need to be released and it needs to happen tonight. IMO